Precision Reimbursement for Precision Medicine: Using Real‐World Evidence to Evolve From Trial‐and‐Project to Track‐and‐Pay to Learn‐and‐Predict

Basic scientists and drug developers are accelerating innovations toward the goal of precision medicine. Regulators create pathways for timely patient access to precision medicines, including individualized therapies. Healthcare payors acknowledge the need for change but downstream innovation for co...

Descripción completa

Detalles Bibliográficos
Autores principales: Eichler, Hans‐Georg, Trusheim, Mark, Schwarzer‐Daum, Brigitte, Larholt, Kay, Zeitlinger, Markus, Brunninger, Martin, Sherman, Michael, Strutton, David, Hirsch, Gigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299639/
https://www.ncbi.nlm.nih.gov/pubmed/34716918
http://dx.doi.org/10.1002/cpt.2471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299639/
https://www.ncbi.nlm.nih.gov/pubmed/34716918
http://dx.doi.org/10.1002/cpt.2471

Ejemplares similares